Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic Suppression
Clinical trial NCT00337467 · COMPLETED
Trial details
- NCT number
- NCT00337467
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2008-05-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.